Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT02661958

Public ClinicalTrials.gov record NCT02661958. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 11:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Multicenter, Double-Blind, Active and Vehicle Controlled Parallel-group Study Evaluating the Efficacy, Safety, and Tolerability of Products S6G5T-3 and S6G5T-1 for the Treatment of Acne Vulgaris for 12 Weeks

Study identification

NCT ID
NCT02661958
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sol-Gel Technologies, Ltd.
Industry
Enrollment
726 participants

Conditions and interventions

Conditions

Interventions

  • S6G5T-3 Drug
  • S6G5T-1 Drug
  • S6G5T-5 Drug
  • S6G5T-6 Drug
  • S6G5T-7 Drug
  • S6G5T-8 Drug

Drug

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2016
Primary completion
Sep 30, 2017
Completion
Sep 30, 2017
Last update posted
Sep 18, 2019

2016 – 2017

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
30
Facility City State ZIP Site status
Orange County Research Institute Anaheim California 92801
Core Healthcare Group Cerritos California 90703
eStudySite Chula Vista California 91911
T. Joseph Raoof MD, Inc./Encino Research Center Encino California 91436
Dermatology Research Associates Los Angeles California 90045
eStudySite Oceanside California 92056
Empire Clinical Research Upland California 91786
Horizons Clinical Research Center, LLC Denver Colorado 80220
MOORE Clinical Research, Inc Brandon Florida 33511
Health Awareness, Inc. Jupiter Florida 33458
LCC Medical Research Institute, LLC Miami Florida 33126
Oceane7 Clinical Research Miami Florida 33144
RM Medical Research, LLC Miami Florida 33175
IMIC Inc. Palmetto Bay Florida 33157
Clinical Research Trials of Florida, Inc. Tampa Florida 33607
Meridien Research Tampa Florida 33634
Heartland Research Associates, LLC Augusta Kansas 67010
Dermatology Specialists Research Louisville Kentucky 40202
DermResearch, PLLC Louisville Kentucky 40217
DelRicht Research New Orleans Louisiana 70115
MediSearch clinical Trials Saint Joseph Missouri 64506
Quality Clinical Research Inc. Omaha Nebraska 68114
eStudySite Las Vegas Nevada 89109
ActivMed Practices and Research, Inc. Portsmouth New Hampshire 3801
New York Clinical Trials Manhattan New York 10018
Derm Research Center of New York, Inc Stony Brook New York 11790
Dermatology Consulting Services High Point North Carolina 27262
Wake Research Associates, LLC Raleigh North Carolina 27612
Paddington Testing Co, Inc Philadelphia Pennsylvania 19103
Palmetto Clinical Trial Services, LLC @ Greenville Dermatology Greenville South Carolina 29607
Discover Research, Inc. Bryan Texas 77802
West Houston Clinical Research Services LLC Houston Texas 77055
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660
Texas Dermatology and Laser Specialists San Antonio Texas 78218

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02661958, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 18, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02661958 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →